Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Amgen Inc (AMGN)  
$318.15 9.99 (3.24%) as of 4:30 Mon 6/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 585,690,000
Market Cap: 186.34(B)
Last Volume: 3,388,705 Avg Vol: 2,717,833
52 Week Range: $218.65 - $324.56
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 100     S&P 500
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  499
Guru Rank Value     : 3
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA™ (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 2,117 2,117 23,771 31,503
Total Sell Value $662,802 $662,802 $6,471,520 $8,438,219
Total People Sold 1 1 3 6
Total Sell Transactions 1 1 4 8
End Date 2024-03-24 2023-12-22 2023-06-23 2022-06-23

   
Records found: 2206
  Page 33 of 89  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Harper Sean E EVP, Research & Development   •       •      –    2016-01-31 4 D $152.73 $99,427 D/D (651) 43,894     -
   Balachandran Madhavan EVP, Operations   •       •      –    2016-01-31 4 GD $0.00 $0 D/D 2,727 20,302     -
   Balachandran Madhavan EVP, Operations   •       •      –    2016-01-31 4 GA $0.00 $0 I/I 2,727 63,738     -
   Balachandran Madhavan EVP, Operations   •       •      –    2016-01-31 4 D $152.73 $87,056 D/D (570) 22,783     -
   Patton Cynthia M SVP & CCO   •       •      –    2016-01-28 4 D $150.47 $46,345 D/D (308) 14,721     -
   Mcnamee Brian M EVP   •       •      –    2016-01-28 4 D $150.47 $82,909 D/D (551) 76,567     -
   Hooper Anthony C EVP, Global Commercial Ops.   •       •      –    2016-01-28 4 D $150.47 $149,718 D/D (995) 164,339     -
   Bradway Robert A Chairman, CEO and President   •       •      –    2016-01-28 4 D $150.47 $369,103 D/D (2,453) 271,865     -
   Harper Sean E EVP, Research & Development   •       •      –    2016-01-28 4 D $150.47 $150,320 D/D (999) 44,281     -
   Balachandran Madhavan EVP, Operations   •       •      –    2016-01-28 4 D $150.47 $139,185 D/D (925) 23,353     -
   Patton Cynthia M SVP & CCO   •       •      –    2015-11-09 4 GD $0.00 $0 D/D 633 15,029     -
   Patton Cynthia M SVP & CCO   •       •      –    2015-10-26 4 D $155.75 $153,725 D/D (987) 15,662     -
   Tross Stuart A SVP, Human Resources   •       •      –    2015-10-25 4 D $155.75 $88,622 D/D (569) 20,696     -
   Mcnamee Brian M EVP   •       •      –    2015-10-25 4 D $155.75 $311,344 D/D (1,999) 77,118     -
   De Carbonnel Francois Director   •       •      –    2015-08-31 4 S $153.84 $769,192 D/D (5,000) 15,150     -
   Hassan Fred Director   •       •      –    2015-08-19 4 B $165.50 $501,562 D/D 3,010 3,582 2.39     -
   Hassan Fred Director   •       •      –    2015-08-04 4 A $0.00 $0 D/D 572 572     -
   Graham Jonathan P SVP, Gen. Counsel & Secy.   •       •      –    2015-08-04 4 A $0.00 $0 D/D 49,199 49,199     -
   Meline David W EVP & CFO   •       •      –    2015-08-01 4 D $176.59 $1,270,742 D/D (7,196) 51,934     -
   Such Annette Louise CAO   •       •      –    2015-07-31 4 D $171.69 $280,026 D/D (1,631) 8,641     -
   Balachandran Madhavan EVP, Operations   •       •      –    2015-07-31 4 GA $0.00 $0 I/I 4,438 61,011     -
   Balachandran Madhavan EVP, Operations   •       •      –    2015-07-31 4 GD $0.00 $0 D/D 4,438 24,278     -
   Balachandran Madhavan EVP, Operations   •       •      –    2015-07-31 4 D $171.69 $831,838 D/D (4,845) 28,716     -
   Pelham Judith C Director   •       •      –    2015-07-31 4 S $180.40 $908,314 D/D (5,035) 11,890     -
   Patton Cynthia M SVP & CCO   •       •      –    2015-06-02 4 S $157.06 $711,482 D/D (4,530) 16,571     -
  2206 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 33 of 89
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us